Source: BioSpace

Haima Therapeutics: Biotechnology Startup Haima Therapeutics Announces the Formation of Scientific Advisory Board

Board includes experts from Case Western Reserve University, Duke University, University of Pittsburgh and Washington University in St. Louis

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Michael Bruckman's photo - CEO of Haima Therapeutics

CEO

Michael Bruckman

CEO Approval Rating

90/100

Read more